People
The agency would have to furlough about 45 percent of its staff.
The new company will focus on developing bispecific antibodies that regulate the immune system.
The company could be hoping the new hire will provide a consultative resource for all health-care regulatory issues.
After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the U.S.
This not the first time Maraganore has tweeted his support for the benefits of immigration.
The company, which now has 11 personnel, is a CRO focused on infectious disease research.
The U.S. Food and Drug Administration is set to rule on Tavalisse (fostamatinib disodium), an oral spleen tyrosine kinase (SYK) inhibitor, for adult patients with chronic or persistent immune thrombocytopenia (ITP) on April 17.
The move is part of the company’s strategy as it shifts from a consumer products company into a health tech company.
The news was disclosed by Ruyi He, MD, Chief Scientist of the CFDA and the Center for Drug Evaluation.
In the world of Alzheimer’s disease research, the names of some companies attempting to find an efficacious therapy stand out.
PRESS RELEASES